SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-160703
Filing Date
2024-06-13
Accepted
2024-06-13 16:07:54
Documents
15
Period of Report
2024-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d774911d8k.htm   iXBRL 8-K 33936
2 EX-99.1 d774911dex991.htm EX-99.1 18116
6 GRAPHIC g774911g0613192124867.jpg GRAPHIC 2334
  Complete submission text file 0001193125-24-160703.txt   189455

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inab-20240612.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inab-20240612_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inab-20240612_pre.xml EX-101.PRE 11697
18 EXTRACTED XBRL INSTANCE DOCUMENT d774911d8k_htm.xml XML 3751
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39692 | Film No.: 241041275
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)